Alkem Laboratories Limited

Price Chart

Risk-Adjusted Performance

Alkem Laboratories Limited (ALKEM) Price Performance

Alkem Laboratories Limited (ALKEM) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR5582.00, up 0.22% from the previous close.

Over the past year, ALKEM has traded between a low of INR4725.03 and a high of INR5890.00. The stock has gained 11.5% over this period. It is currently 5.2% below its 52-week high.

Alkem Laboratories Limited has a market capitalization of $665.98B, with a price-to-earnings ratio of 28.09 and a dividend yield of 0.91%.

About Alkem Laboratories Limited

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally. The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology. It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder. The company was incorporated in 1973 and is headquartered in Mumbai, India.